Marsha Yvonne Morgan

9PUBLICATIONS
47CO-AUTHORS
Nutritional epidemiologyCell development, proliferation and deathComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markersCryptography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 03, 2026
Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathy.

Rebecca Jeyaraj, Harry D Zacharias, Sonam Vadera

|Feb 10, 2025
Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis.

Raquel A Martínez García de la Torre, Julia Vallverdú, Zhenqing Xu

|Mar 14, 2024
Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?

Obinna O Oleribe, Andrew W Taylor-Robinson, Okey C Nwanyanwu

|Nov 15, 2023
COVID-19 and the Liver: A Complex and Evolving Picture.

Simon D Taylor-Robinson, Marsha Y Morgan

|Jul 20, 2023
The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.

Hamish Innes, Marsha Y Morgan, Jochen Hampe

|Feb 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.

Stephan Buch, Aneesh Sharma, Eleanor Ryan

Pageof 2